Notably, digoxin, a commonly used medication for heart disease, was also identified as a potential candidate targeting NANOS1. Its efficacy in treating breast cancer requires further validation, which presents an opportunity to explore its novel therapeutic applications. Here, NANOS1 is linked to heart disorder.